₹ 240
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Based in Mumbai, India, Auro Laboratories Ltd. commenced operations on May 26, 1989. The company primarily deals in active pharmaceutical ingredients (APIs) and also supplies bulk drugs.
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on EV
Data is available to registered users only